HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.
Speaker at International Cancer Conference 2024 - Yan Leyfman
Keynote Presentation (In-Person)
Yan Leyfman, Icahn School of Medicine, United States

Coronavirus disease 2019 (COVID-19), a respiratory illness caused by betacoronavirus SARS-CoV-2, has broad clinical presentations ranging from asymptomatic to fatal outcomes. Due to their immunocompromised status, cancer patients are at an increased risk for severe SARS-CoV-2 inf [....] » Read More

Speaker at International Cancer Conference 2024 - Jianhua Luo
Keynote Presentation (In-Person)
Jianhua Luo, University of Pittsburgh School of Medicine, United States

Hepatocellular carcinoma (HCC) is one of the most lethal cancers for humans. MAN2A1-FER is one of the most frequent oncogenic fusion genes in the HCC. In this report, we showed that MAN2A1-FER ectopically phosphorylated the extracellular domains of PDGFRA, MET, AXL, and N-cadheri [....] » Read More

Speaker at International Cancer Conference 2024 - Yves Marie Robin
Keynote Presentation (In-Person)
Yves Marie Robin, Oscar Lambret Cancer Center, France

Precision medicine, in its quest for rapidly obtained, reliable, precise, accurate and informative  druggable biotargets, prognostic markers or molecular signatures predictive of treatment outcome, is the driving momentum behind patient care nowadays in oncology. The two mod [....] » Read More

Speaker at International Cancer Conference 2024 - Klaus Brusgaard
Keynote Presentation (In-Person)
Klaus Brusgaard, Odense University Hospital, Denmark

Functional pancreatic neuroendocrine tumors (PNETs) may be hereditary or sporadic. Hereditary forms are often caused by MEN1 mutations. The majority of insulinomas are sporadic, solitary and low-grade. The tumorigenesis in sporadic insulinomas is not well described. We describe t [....] » Read More

Speaker at International Cancer Conference 2024 - Michael Thompson
Keynote Presentation (In-Person)
Michael Thompson, University of Toronto, Canada

Ovarian cancer(OC) results in some 150,000 deaths worldwide of nearly 300,000 new cases each year. Unfortunately, only 20% of patients are diagnosed at the early stages (I and II) of the disease when treatment is most effective, leading to a 5-year relative survival rate of only [....] » Read More

Speaker at International Cancer Conference 2024 - Nur Aimi Aliah Zainurin
Oral Presentation (In-Person)
Nur Aimi Aliah Zainurin, Aberystwyth University, United Kingdom

Breast cancer is one of the deadliest cancers with 685,000 deaths and 2.26 million cases reported in 2020. Early detection is crucial for better treatment outcome. Mammography is the gold standard screening modality for breast cancer diagnosis but use of a cost-effective companio [....] » Read More

Speaker at International Cancer Conference 2024 - Mengmeng Li
Oral Presentation (In-Person)
Mengmeng Li, Sun Yat-Sen University Cancer Center, China

Background: Both the incidence of lung cancer and the prevalence of metabolic abnormalities, specifically metabolic syndrome (MetS), have been increasing worldwide. The relationship between MetS and lung cancer remains controversial. We aimed to investigate the association of Met [....] » Read More

Speaker at International Cancer Conference 2024 - Yufeng Wang
Oral Presentation (In-Person)
Yufeng Wang, Xian Jiaotong University, China

Hypoxia is an inherent characteristic feature of the tumor microenvironment of hepatocellular carcinoma (HCC). Hypoxia inducible factors (HIFs), which are in charge of hundres of genes transcription at least, play essential roles in hypoxia-iinduced HCC progression. Increasing ev [....] » Read More

Speaker at International Cancer Conference 2024 - Mane Davtyan
Oral Presentation (In-Person)
Mane Davtyan, Information Systems Department, Armenia

About how pre-trained ML models and patient data analysis can be used to improve the precision and efficacy of breast cancer diagnosis. The speech will show how these approaches can help with the early identification of breast cancer so that doctors can start treatment early and [....] » Read More

Speaker at International Cancer Conference 2024 - Surya Prakash Tadepalli
Oral Presentation (In-Person)
Surya Prakash Tadepalli, Founder President of the Jai Surya Multiple Knowledge Development Organization, India

Introduction: Up until recently, it was thought that cancer may strike without warning. Now, however, we know that each type of cancer has a specific cause, so let's see whether we can treat them all separately. We can now pinpoint the causes of every type of cancer as well a [....] » Read More

Speaker at International Cancer Conference 2024 - Ran Sun
Poster Presentation (In-Person)
Ran Sun, Chongqing Jiulongpo People’s Hospital, China

Breast cancer metastasis can happen even when the primary tumor is relatively small. But the mechanism for such early metastasis is poorly understood. Herein, we report that neurotrophin 4 (NTF4) plays a dual role in breast cancer proliferation and metastasis. Clinical data showe [....] » Read More

Speaker at International Cancer Conference 2024 - Zhang Yuan
Poster Presentation (In-Person)
Zhang Yuan, Shannxi provincial People's hospital, China

The involvement of M2- like tumor assosiated macrophages TAM? in the advancement and treatment of cancers has been widely documented. The objectives of this study was to develop a new signature associated with M2- like TAMs to fore cast the prognosis and tratment response individ [....] » Read More

Speaker at International Cancer Conference 2024 - Madiha Kanwal
Poster Presentation (In-Person)
Madiha Kanwal, BIOCEV, Charles University, Prague, Czech Republic

Cancer is associated with alterations in key cellular pathways, including the aspartate β-hydroxylase (ASPH) pathway. ASPH is an oncogene that is upregulated in various carcinomas and plays a vital role in tumor progression and metastasis. To better understand the mechanisms [....] » Read More

Speaker at International Cancer Conference 2024 - Irina Matei
Keynote Presentation (In-Person)
Irina Matei, Weill Cornell Medicine, United States

Will be Updated Soon...

Speaker at International Cancer Conference 2024 - Tarulata N Chhowala
Oral Presentation (In-Person)
Tarulata N Chhowala, Veer Narmad South Gujarat University, India

Nano magnetite copper (I) complexes are exceptionally antibacterial, anticancer, anti-inflammatory, and antimicrobial capabilities, which have drawn particular attention as a potential class of medicinal medicines. Nano-magnetic copper complexes [Nano-magnetite-Lys@Cu(PPh3)I] and [....] » Read More

Speaker at International Cancer Conference 2024 - Michel Carlos Tommo Tchouaket
Oral Presentation (In-Person)
Michel Carlos Tommo Tchouaket, International Bass Clarinet Research Center, Cameroon

High-risk human papillomavirus (HR-HPV) infections are responsible for 7.7% of cancers in developing countries, mainly cervical cancer. Several studies reveal the presence of numerous oncogenic HR-HPV genotypes worldwide, but the presence and distribution of these genotypes remai [....] » Read More

Speaker at International Cancer Conference 2024 - Bassam Abdul Rasool Hassan
Oral Presentation (In-Person)
Bassam Abdul Rasool Hassan, Alrafidain University College, Iraq

Cancers that initially respond to chemotherapy may develop resistance, leading to unexpected tumor growth. This phenomenon, known as chemotherapy resistance, renders the treatment ineffective in eradicating cancer cells. This situation is profoundly disheartening for everyone inv [....] » Read More

Speaker at International Cancer Conference 2024 - Kaly Keita
Oral Presentation (In-Person)
Kaly Keita, Department of Internal Medicine at the University Hospital Centre of the Point G, Mali

According to the Barcelona Clinic Liver Cancer (BCLC) staging system, only the advanced stage (stage C) hepatocellular carcinoma (HCC) patient is eligible for systemic treatments. In addition to tyrosine kinase inhibitors, multikinase inhibitors and anti-vascular-endothelial gr [....] » Read More

Speaker at International Cancer Conference 2024 - Shahriar Zohourian Shahzadi
Poster Presentation (In-Person)
Shahriar Zohourian Shahzadi, Iran University of Medical Sciences, Iran (Islamic Republic of)

Follicular dendritic cell sarcoma (FDCS) is a rare type of sarcoma that originates from the stromal component of the germinal center of the B-follicle. Its presentation and prognosis vary, as it can be nodal or extranodal, localized or multifocal, and can be fatal in 20% of cases [....] » Read More

Speaker at International Cancer Conference 2024 - Sergio Marchini
Keynote Presentation (Virtual)
Sergio Marchini, Humanitas Research Hospital, Italy

Epithelial ovarian cancer (EOC) is the 5th cancer-related cause of death among women worldwide. EOC is usually diagnosed at an advanced stage when tumour cells have already spread throughout the pelvis in the peritoneal cavity. Five-year survival rate is around 30% in patients wi [....] » Read More

Speaker at International Cancer Conference 2024 - George Zachos
Keynote Presentation (Virtual)
George Zachos, University of Crete, Greece

Chromatin bridges are strings of chromatin connecting the anaphase poles or daughter nuclei and have been linked to tumourigenesis. Chromatin bridges can arise from segregation of interlinked chromosomes after improper resolution of double strand DNA catenates, or from dicentric [....] » Read More

Speaker at International Cancer Conference 2024 - Shinya Tajima
Keynote Presentation (Virtual)
Shinya Tajima, NHO. Shizuoka Medical Centre, Japan

Herein, we would like to present the case of about 80-year-old female. Her chief complaint was bloody nipple discharge in the left breast. She came to our hospital for thorough examination and treatment. Ultrasonography detected intraductal carcinoma of about 10mm spreading. The [....] » Read More

Speaker at International Cancer Conference 2024 - Romi Gupta
Oral Presentation (Virtual)
Romi Gupta, University of Alabama, United States

Ovarian cancer is a complex disease associated with multiple genetic and epigenetic alterations. The emergence of treatment resistance in most patients causes ovarian cancer to become incurable, and novel therapies remain necessary. We identified epigenetic regulator ATPase famil [....] » Read More

Speaker at International Cancer Conference 2024 - Ned Kinnear
Oral Presentation (Virtual)
Ned Kinnear, Flinders Medical Centre, Australia

Introduction & objectives: For localised tumours of the fifteen most lethal cancers globally, we aimed to compare both biopsy recommendations from leading guidelines and biopsy outcomes. Materials and methods: The most lethal fifteen malignancies globally were determi [....] » Read More

Speaker at International Cancer Conference 2024 - Marie Louise Hammarstrom
Oral Presentation (Virtual)
Marie Louise Hammarstrom, Umea University, Sweden

Colorectal cancer is globally one of the most prevalent cancers and a common cause of cancer-related mortality. The curative treatment is surgery. Unfortunately, recurrence is common with approximately 25% of the patients having relapse. Lymph node (LN) metastasis is the single m [....] » Read More

Speaker at International Cancer Conference 2024 - Sujoy Neogi
Oral Presentation (Virtual)
Sujoy Neogi, Maulana Azad Medical College, India

We present three cases of benign pediatric tumors in which there was significant diagnostic dilemma. We share our experience how a pre-sacral dermoid cyst gave rise to bowel bladder obstruction and subsequent incontinence, a retroperitoneum teratoma just superior to left kidney m [....] » Read More

Speaker at International Cancer Conference 2024 - Yihua Zhong
Oral Presentation (Virtual)
Yihua Zhong, Department of Gastroenterology, Chongqing University Cancer Hospital, Chongqing, China, China

Gastrointestinal metastases of lung cancer are relatively uncommon, yet occur at a higher frequency than would be expected among patients that exhibit a longer survival interval. Metastases that arise in the small intestines are often associated with no or few symptoms such that [....] » Read More

Speaker at International Cancer Conference 2024 -  Borasisi Gabrielle Chenge
Oral Presentation (Virtual)
Borasisi Gabrielle Chenge, University of Lubumbashi, Congo, the Democratic Republic of the

Introduction: Lubumbashi is the 2nd city in the DRC, 2,812,000 inhabitants (2023). Its pediatric oncology unit (CUL) works in collaboration with ophthalmologists, pathologists, surgeons, imagers, etc…(RCP). Financially supported by several NGOs including AMCC, GFAOP&h [....] » Read More

Speaker at International Cancer Conference 2024 - Yasmeen
Oral Presentation (Virtual)
Yasmeen, Women Medical and Dental College, Pakistan

Chemotherapy, which is one of the gold standard management for cancer, brings with it a diverse range of side effects. Cancer has been described as a metabolic disease characterized by dysfunctional mitochondria and probably this is the reason why cancer cells shifts their metabo [....] » Read More

Speaker at International Cancer Conference 2024 - Fateme Yazdaniserajkelaye
Oral Presentation (Virtual)
Fateme Yazdaniserajkelaye, Iran University of Medical Sciences, Iran (Islamic Republic of)

Introduction: Esophageal cancer is a challenging disease because it is aggressive and has limited treatment options. T-DM1, a medication targeting HER2-positive cancer cells, has shown promise in improving patient outcomes. However, drug resistance is still a significant obs [....] » Read More

Speaker at International Cancer Conference 2024 - Frederick H Silver
Oral Presentation (Virtual)
Frederick H Silver, Robert Wood Johnson Medical School, Rutgers University, United States

We have developed a new noninvasive technique termed vibrational optical coherence tomography (VOCT) to optically image and measure the resonant frequency of cellular, blood vessel, papillary collagen, and fibrotic tissue in the skin. Preliminary results on normal skin indicate t [....] » Read More

Speaker at International Cancer Conference 2024 - Zhixiong Chen
Poster Presentation (Virtual)
Zhixiong Chen, Chongqing University Cancer Hospital, China

Background: Placement of self-expandable metal stents (SEMS) by endoscopy has become a recommend treatment for esophagojejunal anastomotisis leakage (EJAL). There is no clear conclusion on whether neoadjuvant therapy will increase the incidence of EJAL in adenocarcinoma of the ga [....] » Read More

Speaker at International Cancer Conference 2024 - Ouassima Erefai
Poster Presentation (Virtual)
Ouassima Erefai, Ibn Tofail University, Morocco

As the Coronavirus Disease 2019 (COVID-19) pandemic continues to pose a global health challenge, its impact on vulnerable populations, particularly those with lung neoplasms, has been profound. This systematic review aimed to delineate the range of COVID-19-related complications [....] » Read More

Watsapp